Share Twitter LinkedIn Facebook Email Daniel Goldstein MD Tel Aviv University discusses Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia